Remove topics digital-health-indicator
article thumbnail

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Digital Health Global

(Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).

article thumbnail

HIMSS22 in Riyadh: Exploring cross-border collaboration in the Middle East

Healthcare IT News - Telehealth

An expert panel will gather during the first day of the event to discuss how digital health can be improved via cross-border collaborations. The purpose of cross-collaboration is to improve aspects in digital healthcare, such as quality, outcomes, safety, interoperability, sustainability, and accessibility of care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity.

article thumbnail

DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics

Digital Health Global

Proceeds will be used to advance two drugs in development, SM-020, a topical novel AKT kinase inhibitor for the treatment of seborrheic keratoses (SKs), and SM-030, a topical novel PKC-beta inhibitor for the treatment of melasma and other hyperpigmentation disorders of the skin. million Series B first close and $8.1

article thumbnail

Global Digital Patient Monitoring Devices Market 2023-2030: COVID-19 Highlighted the Paramount Importance of Digital Patient Monitoring, Igniting Its Demand and Cementing Its Role in Modern Healthcare – ResearchAndMarkets.com

Digital Health Global

DUBLIN–(BUSINESS WIRE)–The Digital Patient Monitoring Devices Global Market Outlook to 2030 report has been added to ResearchAndMarkets.com’s offering. Projections indicate that by 2030, this market will soar to an impressive USD 692.34 billion, riding on a remarkable compound annual growth rate (CAGR) of 25.6%

article thumbnail

The influence of AI-powered chatbots on urolithiasis treatment

Digital Health Global

The study on patients in treatment for urolithiasis In a study recently published in the Journal of Digital Health , Seong Hwan Kim and other authors analyzed a case study involving patients undergoing treatment for urolithiasis , a condition characterized by the formation of stones in the urinary tract.

article thumbnail

Equity, AI, and EMR Maturity at HIMSS23

Healthcare IT Today

More Focus on Equity a Welcome Trend at HIMSS23 – Divurgent Christopher Kunney, Senior VP of Digital Acceleration at Divurgent had a lot of interesting insights to share about equity in healthcare. The Committee also works to address health issues in underserved communities.

EMR 59